Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACP1 | P24666 | 1/20 | 0.40 |
| ▸ | GSR | P00390 | 3/20 | 0.40 |
| ▸ | TERT | O14746 | 7/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.37 |
| ▸ | MC4R | P32245 | 1/20 | 0.35 |
| ▸ | POT1 | Q9NUX5 | 1/20 | 0.35 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4743769 | 0.93 | LCK (0.41) | GSRMC4R | |
| SCHEMBL14069128 | 0.89 | MC4R (0.41) | GSRHRH3KCNH2MC4RMCHR1 | |
| SCHEMBL4748222 | 0.89 | HRH3 (0.47) | ACP1GSRHRH3KCNH2MC4R | |
| SCHEMBL4744848 | 0.89 | GSR (0.40) | GSRHRH3KCNH2MC4RMCHR1 | |
| SCHEMBL4748220 | 0.87 | GSR (0.48) | GSRHRH3KCNH2MC4R | |
| SCHEMBL4743742 | 0.87 | GSR (0.42) | GSR | |
| SCHEMBL4747148 | 0.86 | HRH3 (0.39) | ACP1HRH3MC4R | |
| SCHEMBL4743800 | 0.84 | HRH3 (0.38) | ACP1HRH3MC4R | |
| SCHEMBL4744200 | 0.80 | GSR (0.46) | GSRMCHR1 | |
| SCHEMBL4743737 | 0.79 | GSR (0.48) | GSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008114009-A1 | 10H-BENZO(G)PTERDINE-2,4-DIONE COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | CAMBRIDGE ENTERPRISE LTD. (GB) | 2008-09-25 | — | — | WO | disclosed |
| WO-2008114009-A1 | 10H-BENZO(G)PTERDINE-2,4-DIONE COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | CAMBRIDGE ENTERPRISE LTD. (GB) | 2008-09-25 | — | — | WO | disclosed |